Severe tumor lysis syndrome during the induction therapy for the
treatment of blastic plasmacytoid dendritic cell neoplasm from
Blastic plasmacytoid dendritic cell neoplasm is a rare disease with
difficulty in diagnosis, and clinical courses of patients with BPDCN
vary widely. We report a case of a 63-year-old man with BPDCN showing
severe tumor lysis syndrome (TLS). BPDCN with high tumor burden should
be carefully considered to prevent TLS.